Journals / Van Tıp Dergisi / 2022 / Cilt: 29 - Sayı: 1

Approaches to Dyslipidemia Treatments of Doctors of Family Medicine Discipline in Different Steps

Aile Hekimliği Disiplininin Değişik Basamaklarındaki Hekimlerin Dislipidemi Tedavilerine Yaklaşımları

Pages
2–12
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, it was concluded that residents and specialist family physicians diagnosed and treated more dyslipidemia than general practitioners.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiovascular diseases are the leading causes of death in our country and in the world.
📊
Key Findings & Data:Methods: Our study was conducted between 01.01.2019 - 01.03.2019 in 189 (73%) of 259 family physicians actively working in the city of Kadikoy and its district, with face-to-face interviews and online survey filling.
💡
Conclusion & Impact:In our study, it was concluded that residents and specialist family physicians diagnosed and treated more dyslipidemia than general practitioners.
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Cardiovascular diseases are the leading causes of death in our country and in the world. In our study, we aimed to show the approach of physician s at different academic stages in family medicine discipline to the treatment of dyslipidemia, which is one of the most important risk factors of cardiovascular diseases. Methods: Our study was conducted between 01.01.2019 - 01.03.2019 in 189 (73%) of 259 family physicians actively working in the city of Kadikoy and its district, with face-to-face interviews and online survey filling. Opinions of the physicians participating in the study about their dyslipidemia and statin treatment were obtained with a questionnaire consisting of 32 questions about the demographic data, diagnosis and follow-up of dyslipidemia patients, their knowledge and experience about statin treatment. Results: It was observed that resident family physicians followed more chronic diseases than both specialist and general practitioners. Specialist family physicians think that they have more information about the diagnosis and treatment of dyslipidemia than general practitioner family physicians and general practitioner family physicians. It has been observed that assistant and specialist family physicians follow drug efficacy, duration of treatment and side effects more than general practitioners. 29.8% (n=25) of practitioner fami ly physicians, 50.8% of assistant family physicians (n=31) and 68.3% (n=28) of specialist family physicians stated that they follow the latest guidelines. It has been observed that specialist family physicians follow more guidelines than assistant family physicians and assistant family physicians follow general practitioners. Conclusion: The diagnosis, treatment and follow-up of dyslipidemia by family physicians according to current guidelines will reduce the accumulation in 2nd and 3rd level healthcare facilities. In our study, it was concluded that residents and specialist family physicians diagnosed and treated more dyslipidemia than general practitioners.

Özet

Amaç: Kardiyovasküler hastalıklar ülkemizde ve dünyada önde gelen ölüm nedenlerindendir. Çalışmamızda aile hekimli ği disiplininde farklı akademik aşamalardaki hekimlerin kardiyovasküler hastalıkların en önemli risk faktörlerinden dislipideminin tedavisine yaklaşımını göstermeyi amaçladık. Gereç ve Yöntem: Çalışmamız Kadıköy ve ilçesinde aktif olarak çalışan 259 aile hekiminin 189'una ulaşılarak 01.01.2019 - 01.03.2019 tarihleri aras ında yüz yüze görüşme veya online anket doldurma yöntemiyle gerçekleştirildi. Çal ışma bulguları, katılan hekimlerin dislipidemi ve statin tedavisi ile ilgili görüşleri, dislipidemik hastaların demografik verileri, tan ı ve takibi, statin tedavisi hakk ındaki bilgi ve deneyimleri hakkında 32 sorudan oluşan bir anket ile elde edilmiştir. Bulgular: Asistan aile hekimlerinin hem uzman hem de pratisyen hekimlere göre daha fazla kronik hastalık izlediği gözlendi dislipidemi tanısı ve tedavisi hakkında uzman aile hekimlerinin, asistan ve pratisyen aile hekimlerine göre daha fazla bilgi sahibi olduklarını düşündükleri saptand ır. Asistan ve uzman aile hekimlerinin statin tedavisinin yan etkilerini pratisyen hekimlere göre daha fazla takip ettikleri ortaya çıktı. Pratisyen aile hekimlerinin %29.8'i (n=25), asistan aile hekimlerinin %50.8'i (n=31) ve uzman aile hekimlerinin %68.3'ü (n=28) en son ç ıkan tan ı ve tedavi kılavuzlarına uyduklarını belirtti. Uzman aile hekimlerinin asistan aile hekimlerine ve asistan aile hekimlerinin pratisyen hekimlere gö re daha fazla kılavuz takip ettikleri gözlendi. Sonuç: Aile hekimlerinin güncel kılavuzlara göre dislipidemi tanısı koyup tedavi ve takip etmesi 2. ve 3. basamak sağlık tesislerinde birikimi azaltacaktır. Çalışmamızda asistan ve uzman aile hekimlerinin pratisyen aile hekimlerine göre daha çok dislipidemi tanısı koyup tedavi ettikleri sonucu ortaya çıkmıştır.

🔖

Cite This Article

Karahan, H., Mutlu, H. H., Mutlu, H. H., Öztürk, S. (2022). Approaches to Dyslipidemia Treatments of Doctors of Family Medicine Discipline in Different Steps. Van Tıp Dergisi, Cilt: 29 - Sayı: 1, 2–12. https://ajindex.com/articles/645898

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cardiovascular Diseases 2020, World Health Organization, https://www.who.int/health- topics/cardiovascular-diseases/#tab=tab_1, (ET.15.04.2020
  2. Nunez-Cortes JM, Gimilio JFA, Alonso VB, Amenos AC, Fuster VP, Montoya JP-B, et al. Prescription Habits for Statins in Patients with Impaired Glucose Metabolism. Results of a program with Focus Groups to Assess the Selection Criteria; Am J of Card and Cardiovas Disc. 2019;1(1):01-6
  3. Teramoto T, Uno K, Miyoshi I, Khan I, Gorcyca K, Sanchez RJ, et al. Low-density lipoprotein cholesterol levels and lipid- modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan; Atherosclerosis 2016;251:248-254
  4. Schoen MW, Salas J, Scherrer JF, Buckhold FR. Cholesterol treatment and changes in guidelines in an academic medical practice. Am J Med 2015;128(4):403-409
  5. Tomasik T, Windak A, Seifert B, Kersnik J, Kijowska V, Dubas K. Lipid-lowering pharmacotherapy in Central and Eastern European countries in cardiovascular prevention: self-reported prescription patterns of primary care physicians; J Cardiovasc Pharmacol Ther 2013;18(3):234- 242
  6. Alsancak AD, Gümüş E, Dincer G, Tekin O, Alsancak Y, Dincer ZS. Statin tedavisinde hasta uyumu: Medya ne kadar etkili? Türk Aile Hekimliği Derg 2016;20(1):23-28
  7. Stack PS, Ogola GO. Survey of Personal Use of Statins by Prescribers. Am J Cardiol 2020;125(4):549-552
  8. Tušek-Bunc K, Kersnik J, Petek-Šter M, Petek D, Klemenc-Ketiš Z. Explanatory model of prescribing behavior in prescription of statins in family practice. Wiener Klinische Wochenschrift 2010;122(2):79-84
  9. Keskin A. Status of Reaching LDL Goals In Diabetic Patients and Frequency of Statin Treatment Compliance. Ankara Med J 2012;12(3):122-123
  10. Svensson E, Nielsen RB, Hasvold P, Aarskog P, Thomsen RW. Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study. J Clin Epidemiol 2015;7:213
  11. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999- 2002 and 2005-200. Centers for Disease Control and Prevention, http://www.cdc.gov/mmwr. (ET.15,04,2020
  12. Ferrajolo C, Arcoraci V, Sullo MG, Rafaniello C, Sportiello L, Ferrara R, et al. Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment? PloS one 2